Abstract
For the mechanistic study of arrhythmias in clinical practice the terms “arrhythmogenic substrate”, “initiating factor” and “modulating factors” have been introduced.1 We define the substrate as “a pre-existing condition that forms a prerequisite for the induction of an arrhythmia”. For example in the Wolff-Parkinson-White syndrome the substrate is formed by the accessory bundle and removal of the bundle is curative.2 In clinical cardiology the “substrate” is studied by invasive electrophysiology, whereas the “initiating factor” is primarily the subject of non-invasive electrophysiologic studies. Although this approach has proved valuable in the study of the substrate in AV-reentrant arrhythmias it fell short in the mechanistic evaluation of ventricular arrhythmias.1 In ventricular myocardium, multiple mechanisms may underlie the inducibility of a sustained arrhythmia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference List
Coumel P: The management of clinical arrhythmias. An overview on invasive versus noninvasive electrophysiology. Eur Heart J 1987;8:92–99
Wellens HJJ, Janse MJ, van Dam RT, van Capelle FJL, Meijne NG, Mellink HM, Durrer D: Epicardial mapping and surgical treatment in W.P.W. syndrome type A. Am Heart J 1974;88:69–78
Coronel R: Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion. Implications for arrhythmogenesis. Cardiovasc Res 1994;28:770–777
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N.Engl.J.Med. 1989;321:406–412
Smith IV WT, Fleet WF, Johnson TA, Engle CL, Cascio WE: The 1B phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell coupling. Circulation 1995;92:3051–3060
Manning AS, Coltart DJ, Hearse DJ: Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res 1984;55:545–548
Coronel R, Wilms-Schopman FJG, Janse MJ: Profibrillatory effects of intracoronary thrombus in acute regional ischemia of the in situ porcine heart. Circulation 1997;96:3985–3991
Bigger T: Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987;75:IV-28–IV-35
Goldstein S, Brooks MM, Ledingham R, Kennedy HL, Epstein AE, Pawitan Y, Bigger JT: Association between ease of suppression of ventricular arrhythmia and survival. Circulation 1995;91:79–83
Kennedy HL, Brooks MM, Barker AH, Bergstrand R, Huther M, Beanlands DS, Bigger JT, Goldstein S: Beta-blocker therapy in the cardiac arrhythmia suppression trial. Am J Cardiol 1994;74:674–680
Willems AR: Determinants of mortality in late ventricular tachycardia or fibrillation after myocardial infarction. Eur Heart J 1988;9:266 (Abstract)
Thakur RK, Guiraudon GM, Klein GJ, Yee R, Guiraudon CM: Intraoperative mapping is not necessary for VT surgery. Pacing.Clin.Electrophysiol. 1994;17:2156–2162
Guiraudon GM, Thakur RK, Klein GJ, Yee R, Guiraudon CM, Sharma A: Encircling endocardial cryoablation for ventricular tachycardia after myocardial infarction: experience with 33 patients. Am.Heart J. 1994;128:982–989
Van Hemel NM, Kingma JH, Defauw JA, Vermeulen FE, Mast EG, Ernst JM, Ascoop CA: Left ventricular segmental wall motion score as a criterion for selecting patients for direct surgery in the treatment of postinfarction ventricular tachycardia. Eur.Heart J. 1989; 10:304–315
Ostermeyer J, Borggrefe M, Breithardt G, Podczek A, Goldmann A, Schoenen JD, Kolvenbach R, Godehardt E, Kirklin JW, Blackstone EH, et al: Direct operations for the management of life-threatening ischemic ventricular tachycardia. J.Thorac.Cardiovasc.Surg. 1987;94:848–865
Platia EV, Griffith LS, Watkins LJ, Mower MM, Guarnieri T, Mirowski, Reid PR: Treatment of malignant ventricular arrhythmias with endocardial resection and implantation of the automatic cardioverter-defibrillator. N.Engl.J.Med. 1986;314:213–216
Lawrie GM, Wyndham CR, Krafchek J, Luck JC, Roberts R, DeBakey ME: Progress in the surgical treatment of cardiac arrhythmias. Initial experience of 90 patients. JAMA 1985;254:1464–1468
De Bakker JMT, Coronel R, Tasseron S, Wilde AAM, Opthof T, Janse MJ, Van Capelle FJL, Becker AE, Jambroes G: Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: Role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol 1990;15:1594–1607
de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de, Jonge N, Lahpor JR: Slow conduction in the infarcted human heart. ‘Zigzag’ course of activation. Circulation 1993;88:915–926
Belichard P, Pruneau D, Brown NL, Salzmann JL, Rouet R: Hypertrophie myocardique hypertensive et troubles du rhythme: deux origines probables. Arch Mal.Coeur.Vaiss. 1989;82:1303–1308
Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OHL: Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995;91:161–170
Dunn FG, Pringle SD: Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy. JHypertens. 1993;11:1003–1010
Messerli FH, Soria F: Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death. Cardiovasc Drug Therapy. 1994;8:557–563
Weber JR: Left ventricular hypertrophy: Its prevalence, etiology, and significance. Clin Cardiol 1991;14:13–17
Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H: Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am.Heart J. 1988;116:1455–1463
Kjekshus J: Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990;65:42I-481
Vermeulen JT, McGuire MA, Opthof T, Coronel R, de Bakker JMT, Klopping C, Janse MJ: Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res 1994;28:1547–1554
Vermeulen JT, Tan HL, Rademaker H, Schumacher CA, Loh P, Opthof T, Coronel R, Janse MJ: Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit myocardium. J Mol Cell Cardiol 1996;28:123–131
Rademaker, H. Arrhythmogenesis during the development of heart failure in rabbits. 1–127. 1997. Amsterdam, Ponsen & Looijen, Wageningen.
Pye MP, Black M, Cobbe SM: Comparison of in vivo and in vitro haemodynamic function in experimental heart failure: use of echocardiography. Cardiovascular Research 1996;31:873–881
Pye MP, Cobbe SM: Arrhythmogenesis in experimental models of heart failure: the role of increased load. Cardiovascular Research 1996;32:248–257
Belichard P, Savard P, Cardinal R, Nadeau R, Gosselin H, Paradis P, Rouleau JL: Marked different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol 1994;23:505–513
Aronson R, Ming Z: Cellular mechanisms of arrhythmias in hypertrophied and failing myocardium. Circulation 1993;87:76–83
Mcintosh MA, Cobbe SM, Smith GL: Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res 1999;in press
Tomaselli GF, Marban E: Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999;42:270–283
Pinto JMB, Boyden PA: Electrical remodeling in ischemia and infarction. Cardiovasc Res 1999;42:284–297
Bril A, Forest MC, Gout B: Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure. Am J Physiol 1991;261:H301–H307
Hart G: Cellular electrophysiology in cardiac hypertrophy and failure — Review Article. Cardiovasc Res 1994;28:933–946
Vermeulen JT, Baartscheer T, Schumacher CA, Belterman C, Fiolet JWT, Coronel R, Janse MJ: Ventricular arrhythmias in failing hearts are related to calcium aftertransients. Circulation 1998;98:I–679
Prestle J, Dieterich S, Preuss M, Bieligk U, Hasenfuss G: Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 1999;43:323–331
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Coronel, R., Baartscheer, A., Rademaker, J.M.E., Vermeulen, J.T., de Bakker, J.M.T. (2001). The Arrhythmogenic Substrate in Ischemic and Non-ischemic Cardiomyopathies. In: Liem, L.B., Downar, E. (eds) Progress in Catheter Ablation. Developments in Cardiovascular Medicine, vol 241. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9791-3_1
Download citation
DOI: https://doi.org/10.1007/978-94-015-9791-3_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5882-9
Online ISBN: 978-94-015-9791-3
eBook Packages: Springer Book Archive